Join

Compare · CNTQ vs TMO

CNTQ vs TMO

Side-by-side comparison of Chardan NexTech Acquisition 2 Corp. (CNTQ) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.

Summary

  • CNTQ operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
  • TMO is the larger of the two at $174.49B, about 1104.6x CNTQ ($158.0M).
  • TMO has hit the wire 6 times in the past 4 weeks while CNTQ has been quiet.
  • TMO has more recent analyst coverage (25 ratings vs 0 for CNTQ).
MetricCNTQTMO
Company
Chardan NexTech Acquisition 2 Corp.
Thermo Fisher Scientific Inc
Price
$13.79-9.16%
$469.57+0.63%
Market cap
$158.0M
$174.49B
1M return
-
-4.31%
1Y return
-
+11.45%
Industry
Industrial Machinery/Components
Industrial Machinery/Components
Exchange
NASDAQ
NYSE
IPO
2021
News (4w)
0
6
Recent ratings
0
25
CNTQ

Chardan NexTech Acquisition 2 Corp.

Chardan NexTech Acquisition 2 Corp. intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in New York, New York.

TMO

Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.

Latest CNTQ

Latest TMO